InvestorsHub Logo

PickleNick

07/16/19 9:35 AM

#28624 RE: ApollyonZ #28618

It’s to bad this failed credit card processing company has nothing to do with them, and in one week you’ll come to that same conclusion.

It’s not all bad though, the shares the company dumped, they are sitting on about $9M cash. Plus they still have about 300,000,000 shares left to dump, figure they end with $10M.

Even when whatever is supposed to happen on 7/22, doesn’t, I mean cmon, let’s be real. When it doesn’t, at least the company will have about $10M to make a real move.

That won’t happen for roughly 2-3 months however.

ApollyonZ

07/17/19 2:58 PM

#29252 RE: ApollyonZ #28618

$LAHO REG..MED..USDHHS..conservatively estimated..$500 billion by 2020

Regenerative medicine will dramatically alter the U.S. healthcare industry

..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..

An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:

250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually

..By doing so, we can make tissue and organ failure a relic of the past by 2020.

Interagency Federal Working Group on Regenerative Medicine

Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services

National Institutes of Health

Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD

Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD

http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html


$LAHO FANTASTIC$